ArticleThe Biochemical journal2018

Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutants.

Diego Avellaneda Matteo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.